Primary Cicatricial Alopecias in Black Women
Hair Apparent: A Multi-Part Series on Hair Disorders - Part II
If you missed Part I, click here.
Dermatology residents from throughout the Washington DC area recently convened at the Georgetown University MedStar Washington Hospital Center Hair Disorders Symposium, where distinguished experts in the field of hair disorders discussed the evaluation, work-up, and treatment of a wide variety of a …
Hair Apparent: A Multi-Part Series on Hair Disorders - Part II
If you missed Part I, click here.
Dermatology residents from throughout the Washington DC area recently convened at the Georgetown University MedStar Washington Hospital Center Hair Disorders Symposium, where distinguished experts in the field of hair disorders discussed the evaluation, work-up, and treatment of a wide variety of a … Continue reading "Primary Cicatricial Alopecias in Black Women"
Skin conditions affect tens of millions of people across the United States with symptoms that range from purely cosmetic to downright painful—and in some cases lethal. In addition, skin conditions can signal deeper problems. For example, patients with psoriasis are at a higher risk because of associated comorbidities such as chronic pulmonary disease, diabetes, renal disease, and rheumatic disea … 
My Obsession with Cutaneous T-Cell Lymphoma (CTCL) – A Sneak Peek
In preparation for an exciting new Resident-led session at the upcoming ODAC conference, titled “My Obsession with CTCL”, I wanted to give you an overview of this broad category of diseases. I just remember my first Dermatology Grand Rounds presentation as a new resident was covering the topic of sarcoidosis. In this discussi … 
The patient developed this cutaneous adverse reaction 2 weeks after starting a clinical trial medication. What is the mechanism of action of the culprit medication?
A). Epidermal growth factor receptor (EGFR) inhibitor
B.) Tumor necrosis factor (TNF)-alpha inhibitor
C.) Smoothened inhibitor
D.) BRAF inhibitor
E.) Programmed cell death (PD)-1 inhibitor
To find out the correct answer a … 
The second of a two-part series with clinical pearls for your dermatology practice from the 2018 Coastal Dermatology Symposium. Be sure not to miss all the useful points in Part I.
From Dr. Julie Harper’s talk “The Latest on Acne”
OCPs are still a viable treatment for female patients with acne. You should be sure to take a thorough history to elucidate any risk factors for venous t … 